Trinidad and Tobago vs Ukraine: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Trinidad and Tobago
0.1%
in 2024
Ukraine
0.1%
in 2024
Trinidad and Tobago rank
134th
Ukraine rank
134th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Trinidad and Tobago
- Ukraine
How they compare
Trinidad and Tobago currently reports 0.1% against 0.1% in Ukraine, a difference of 0.0%.
Across all 10 years both countries report, Ukraine has been ahead every year.
Trinidad and Tobago ranks 134th and Ukraine ranks 134th of 246 countries.
Ukraine has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Trinidad and Tobago | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.1% | Ukraine |
| 2020s | 0.1% | 0.1% | 0.0% | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Trinidad and Tobago or Ukraine?
- Trinidad and Tobago, at 0.1% against 0.1% in Ukraine as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Trinidad and Tobago and Ukraine?
- 0.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and Ukraine?
- 10 years are reported by both, from 2015 to 2024.
- How do Trinidad and Tobago and Ukraine rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Trinidad and Tobago ranks 134th and Ukraine ranks 134th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.